FDA Inspection
Bahman GuyuronBahman Guyuron – FDA Inspection, Jun 21, 2017
Record Details
This FDA Inspection record concerns Bahman Guyuron, with an inspection on June 21, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 7f356742-5071-4e5d-a90b-d2d3d27bd022
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1015061
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
- Outcome
- Form 483 issued
FDA Citations
5- 21 CFR 312.60FD-1572, protocol compliance
- 21 CFR 312.62(b)Case history records- inadequate or inadequate
- 21 CFR 312.66Unanticipated problems
- 21 CFR 50.27(a)Consent form not approved/signed/dated
- 21 CFR 312.62(a)Accountability records
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.